| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |